Clinical Trials · NCT01533532
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Enrollment
- 100
- Start date
- Not specified
- Locations
- 1 site, Japan
- Primary endpoint
- The severity score of the pelvic pain